Advertisements

Неотризол

Quick links to important sections

Неотризол

Selected form

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Неотризол

What is Неотризол? Quick Facts

Property Description
Active Ingredients Miconazole Nitrate, Neomycin, Ornidazole, Prednisolone Acetate
Form Vaginal Suppositories (Pessaries/Ovules)
Pharmacological Class Topical Anti-infective and Corticosteroid Combination
General Purpose Addressing Mixed Vaginal Conditions (Anti-Infective & Anti-inflammatory)
Origin Synthetic Combination Product

What Type of Medicine is Неотризол? (Identity and Classification)

Неотризол is classified as a synthetic, multicomponent antimicrobial and anti-inflammatory gynecological preparation designed specifically for local treatment. This product belongs to the high-level Topical Anti-infective and Corticosteroid Combination pharmacological class. Its formulation is provided as vaginal suppositories (pessaries or ovules), confirming its intended local route of administration directly at the affected site. The combination of four distinct active compounds provides a clinical strategy recognized for its ability to address multiple types of pathogens simultaneously.

Composition of Неотризол: A Four-Component Approach

The preparation's defining characteristic is its comprehensive tetra-component composition, which includes four distinct active ingredients: Miconazole Nitrate (an imidazole antifungal agent), Neomycin (an aminoglycoside antibiotic, derived from Streptomyces fradiae), Ornidazole (a nitroimidazole antiprotozoal/antibacterial agent), and Prednisolone Acetate (a synthetic corticosteroid). These active agents are incorporated into a lipophilic base that melts at body temperature, facilitating their release within the vagina. Neomycin is categorized as a broad-spectrum aminoglycoside antibiotic used to treat bacterial infections.

General Purpose: Addressing Mixed Vaginal Conditions

The general purpose of Неотризол is to address mixed or complex infections in the vaginal area by concurrently targeting multiple microbial threats and managing inflammation. The combination of anti-infective agents ensures broad activity against the common causes of vaginitis—fungi, bacteria, and protozoa. Simultaneously, the Prednisolone Acetate component provides a rapid, powerful local anti-inflammatory effect to quickly reduce the swelling, redness, and irritation that accompany these infections, leading to early symptom relief.

Regulatory References

  1. Neomycin
  2. Ornidazole
  3. Prednisolone Acetate
Advertisements

What side effects are possible with Неотризол?

Possible side effects and safety information

The official safety profile for the combination vaginal suppository Неотризол is structured around local reactions and the rare, potential systemic effects derived from its active components (Miconazole, Neomycin, Ornidazole, Prednisolone).


Frequency-Classified Adverse Reactions

Adverse reactions are classified based on the frequency reported in clinical use and regulatory documents:

  • Common: Adverse effects most frequently documented are local application site reactions, including pruritus (itching), a burning sensation, irritation, and erythema (redness).
  • Uncommon/Rare: Local hypersensitivity reactions, such as contact dermatitis, may occur. Systemic effects are listed as rare or Frequency Not Known given the topical route, but are noted due to potential absorption.

Documented Safety Considerations

The safety profile includes specific high-level concerns related to the components and duration of use, as documented in regulatory sources:

Safety Domain Regulatory Focus
Systemic Risks The rare potential for Ototoxicity and Nephrotoxicity is a serious, class-specific concern linked to Neomycin absorption, particularly with prolonged use or damaged mucosa. Potential HPA axis suppression is also noted for the Prednisolone component.
Time-Related Patterns Local irritation and burning are often reported as more prominent at the initiation of treatment but may lessen thereafter. Prolonged use increases the risk of systemic absorption and related adverse effects.
Serious Reactions Severe Hypersensitivity Reactions, including anaphylaxis, are documented as rare but serious adverse events.
Restrictions Use is constrained by known hypersensitivity to any component and by documented high-level concerns regarding the Ornidazole component's safety profile when used concurrently with oral anticoagulants or alcohol ingestion.
Advertisements

Overdose and Emergency Response

The official regulatory information regarding overdose for Неотризол is based on the potential for systemic exposure arising from accidental oral ingestion or from excessive, prolonged application of the vaginal suppositories. Overdose manifestations are primarily linked to the known toxicities of the active components, Neomycin and Prednisolone, as documented in governmental sources.

Overdose presentations may include evidence of Nephrotoxicity or Neurotoxicity, which can manifest as convulsions, muscle twitching, or paresthesia. A severe outcome documented for the Neomycin component is the risk of permanent bilateral auditory ototoxicity. Systemic absorption of the Prednisolone component may lead to fluid and electrolyte imbalance (such as hypokalemia and elevated blood pressure) or behavioral and mood disturbances. With chronic excessive use, there is a documented risk of adrenocortical unresponsiveness (HPA axis suppression).

In the event of suspected systemic exposure or the appearance of these signs, regulatory guidance mandates that patients must seek immediate medical attention. The established management procedure involves providing symptomatic and supportive treatment and requires the discontinuation of therapy. Monitoring of renal function and serum electrolytes is also required. Official labeling notes an increased risk of toxicity in vulnerable populations, such as premature infants and neonates. No specific antidote is known for this combination.

Advertisements

Therapeutic Uses of Неотризол

Neotrizol is an established combination medicine used in the treatment of mixed vaginal infections which may involve susceptible bacteria, fungi (yeast), and protozoa.

The medicine is generally employed to help alleviate symptoms of discomfort and address the microorganisms often associated with these common gynecological conditions. The combination of active ingredients assists in targeting the organisms often implicated in conditions such as bacterial vaginosis and vulvovaginal candidiasis (a common yeast or thrush infection). The use of such a combination therapy aligns with the goal of managing the broad spectrum of potential pathogens. The formulation is designed to cover the range of common pathogens that contribute to mixed infections. The treatment option may offer relief for associated symptoms, which frequently include abnormal vaginal discharge, itching, and irritation.

Quick Note: May help address vaginal itching and irritation

Regulatory References

  1. ClinicalTrials.gov website
Advertisements

Eligibility and Restrictions for Use

The eligibility for using Неотризол is determined by official regulatory documents based on patient profile and certain health conditions. The preparation is intended exclusively for use by adult women with mixed vaginal infections susceptible to its active components.

Contraindications and Restrictions

Classification Population or Condition Regulatory Status
Absolute Contraindication Hypersensitivity to any component (Miconazole, Neomycin, Ornidazole, Prednisolone). Severe Liver Dysfunction. Porphyria or Epilepsy. Women in the first trimester of pregnancy. Virgin women.
Conditional/Restricted Use Women in the second and third trimesters of pregnancy (use only if essential under specialist supervision). Women who are breastfeeding (breastfeeding must be discontinued during treatment). Severe Renal Impairment.

Use is generally not recommended or not established in the pediatric population (children and adolescents). Patients with severe hepatic or renal impairment face restrictions due to the potential for increased systemic absorption of the Ornidazole and Neomycin components, which is a key regulatory concern. All eligibility rules are based strictly on the official prescribing information.

Advertisements

What should I know about interactions with other medicines?

The official regulatory documents define the interaction profile of Неотризол based on the systemic potential of its active components, Miconazole, Neomycin, and Ornidazole. Interactions documented in government sources necessitate specific restrictions and monitoring.

Category Interaction Restriction
Oral Anticoagulants The Miconazole component is a documented inhibitor of CYP2C9 and CYP3A4 enzymes. This metabolic interaction increases the plasma concentration and reduces the clearance of drugs like Warfarin. Official caution mandates the careful monitoring and titration of the anticoagulant effect (INR) if co-administered.
Toxic Agents Concurrent or serial use of the Neomycin component with Potent Diuretics (e.g., Furosemide, Ethacrynic acid) or other Neurotoxic / Nephrotoxic Drugs must be avoided. This rule addresses the risk of enhanced toxicity, specifically nephrotoxicity and ototoxicity.
Alcohol (Ethanol) Consumption is strictly contraindicated during treatment and must be avoided for a minimum of 72 hours (3 days) following the final dose. This mandatory separation rule is due to the risk of a Disulfiram-like reaction caused by the Ornidazole component.

Additional exposure-modifying interactions are cited, including the potential for Phenobarbitone or Rifampin to reduce the therapeutic efficacy of the Ornidazole component. The overall risk profile is formally cited as heightened in patient populations such as those with renal insufficiency or advanced age.

Advertisements

Mechanism of Action

Targeting Microbial Protein Synthesis

This domain covers the action of the aminoglycoside antibiotic component. The mechanism involves the drug binding to the 30S ribosomal subunit within susceptible bacterial cells, disrupting protein synthesis. This interference modifies the early molecular steps of peptide elongation, leading to the production of non-functional proteins and subsequent microbial cell death.

Inhibition of Microbial Nucleic Acid Integrity

This refers to the mechanism of the nitroimidazole component. These agents diffuse into anaerobic organisms and are reduced to form reactive intermediates and free radicals. These species chemically interact with and damage microbial DNA, causing strand breakage and loss of the helical structure, which represents a key mechanistic cascade of DNA damage in susceptible organisms.

Modulating Fungal Cell Membrane Structure

This cluster outlines the effect of the azole antifungal component. The drug acts within domains involving key enzyme-mediated signaling by inhibiting lanosterol 14 alpha-demethylase, an essential enzyme in the biosynthesis of ergosterol. Ergosterol depletion leads to membrane instability and leakage, which alters the cellular integrity of the fungal organism.

Regulation of Inflammatory Processes

This domain addresses the action of the corticosteroid component. The steroid engages mechanisms that regulate dysregulated processes by binding to intracellular glucocorticoid receptors. This modulates the expression of various genes involved in inflammation, which inhibits the downstream production of inflammatory mediators like prostaglandins and leukotrienes, resulting in an altered expression profile of inflammatory mediators, modulating the corresponding physiological response.

Advertisements

Dosage and Administration Information

The administration of Неотризол is strictly defined as intravaginal (topical/local), corresponding to its formulation as a vaginal suppository. This route ensures the local delivery of the four active ingredients directly to the treatment site. The general frequency of use for this class of product is typically once daily as part of a fixed, short-term course of treatment, while the specific numeric dosing and total duration are established by healthcare professionals and must be followed as prescribed.

The suppository is administered at night, before bedtime, and while the patient is in a lying position, which aids in retention and optimal distribution. For proper use, the suppository is required to be inserted high into the vagina.

Procedural constraints include the mandate to avoid the concurrent use of other vaginal products (such as douches, spermicides, or tampons). The administration schedule is generally not recommended during the menstrual period, often due to the potential for reduced efficacy.

Furthermore, the lipid excipient base of the suppository may damage latex products, necessitating caution regarding the use of condoms or diaphragms. Regarding specific populations, this product is not intended for use in children under 12 years of age or in young women who are not sexually mature.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Неотризол


Evidence Supporting the Study of Mixed Vaginal Conditions

Research was studied for multi-component vaginal preparations like Неотризол in the context of conditions characterized by fluctuating or episodic manifestations, specifically mixed vaginal infections. Studies have often included observational settings evaluating daily-life functioning and Randomized Controlled Trials (RCTs) involving comparable, though not always identical, component therapies.

Researchers examined outcomes related to physical discomfort, monitoring endpoints such as the clinical cure rate (defined by the resolution of symptomatic signs) and the microbiological cure rate (defined by laboratory confirmation of pathogen eradication). They also monitored the time until symptoms improved. Findings describe patterns observed in the studies, often indicating that research highlights changes measured during the study period for the rate of pathogen clearance and symptom change in the observed populations.


Research on Component Indications (Vaginal Candidiasis and Vaginosis)

A more substantial body of research was studied for the individual anti-infective components within Неотризол, such as Miconazole (antifungal) and Ornidazole/Neomycin (antibacterial/antiprotozoal). This research includes Systematic Reviews and Meta-Analyses that have explored how well these individual agents were evaluated in conditions such as Vulvovaginal Candidiasis (VVC) and Bacterial Vaginosis (BV).

These studies focused on precise microbiological outcomes, such as the elimination of specific pathogens. Trials and reviews reported measurements of microbiological outcomes and associated patient-reported outcomes describing perceived discomfort when these component drugs were evaluated in women diagnosed with VVC or BV. These results align with research categorized as having a High evidence level and primarily describe group patterns, not personal outcomes, and contribute to the broader evidence landscape for treating these specific infections.


Research Gaps and Remaining Uncertainties

The evidence base for Неотризол presents several research limitation frames. The research base for this specific four-component formulation differs from that of single-agent treatments. Furthermore, the full four-drug formulation has not been directly compared in large-scale RCTs against a simpler, two-drug combination. Therefore, the comparative evidence is lacking to determine if the full four-drug combination provides additional patterns of outcome.

Data for certain groups remain insufficient. For instance, evidence is limited regarding how the medicine was studied for special populations, such as women with recurrent or chronic forms of these conditions. Long-term effects are not fully established, meaning the research does not determine whether an individual will respond similarly after six months or a year.

Key Studies & References

  1. Co-Formulated Metronidazole/Miconazole for the Prevention of Recurrent Vaginal Infections (Clinical Trial)
  2. U.S. National Library of Medicine DailyMed: Prednisolone Acetate Label Information
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Неотризол (FAQ)


Q: Can Неотризол cause a change in the taste in the mouth, like a metallic taste?

A: The Ornidazole component in this medication belongs to a class of drugs that are known to have the potential to cause a metallic or unpleasant taste disturbance in the mouth for some patients. This is a recognized side effect that is documented in official safety information for this drug class.

Q: Are there any known interactions between Неотризол and oral contraceptives?

A: Official product labeling generally advises caution regarding the concurrent use of the drug with hormonal contraceptives. Both the antibiotic components and the Miconazole (antifungal) component may potentially affect the metabolism of certain oral contraceptive medicines.

Q: What should a patient do if their symptoms worsen after starting Неотризол?

A: According to general safety principles, patients who observe symptoms that worsen or do not begin to improve while using the medication are advised to contact a healthcare provider to assess the condition and determine appropriate next steps for treatment.

Q: Can Неотризол affect the liver, and if so, what are the official warnings?

A: Неотризол is typically restricted from use in people who have severe liver dysfunction. This restriction exists because the Ornidazole component may accumulate in the body if the liver's function is significantly impaired, which is a key safety consideration.

Q: Are there precautions for people with a history of seizures when using Неотризол?

A: Yes, official documents advise special caution or list Epilepsy as an absolute contraindication for use. This is because the drug's components may potentially have effects on the Central Nervous System (CNS), which must be considered for patients with pre-existing conditions.

Q: Is a low white blood cell count (leukopenia) a potential side effect of Неотризол?

A: The Ornidazole component is associated with potential hematological effects, and there have been occasional reports of leukopenia (a low white blood cell count). Official warnings may advise that blood counts should be monitored, especially in certain patient groups.

Q: Is it considered normal to experience stomach cramps or abdominal pain with Неотризол?

A: Gastrointestinal symptoms such as nausea, diarrhea, or epigastric distress (stomach discomfort) have been reported in safety profiles. These effects are primarily linked to the Ornidazole component, though they may be less frequent when the medication is used topically.

Q: Can the ingredients in Неотризол be absorbed into the body and cause effects elsewhere?

A: Although the drug is administered locally, official documents confirm that its components, such as Neomycin and Ornidazole, have the potential for systemic absorption. This potential is noted to be greater with prolonged use or if the vaginal lining is damaged, leading to rare, systemic effects.

Q: Is Неотризол used for infections other than yeast or bacterial ones?

A: Yes, in addition to addressing yeast and bacterial conditions, the Ornidazole component is specifically included to treat infections caused by susceptible protozoa. This includes organisms such as Trichomonas vaginalis, which contributes to its use for mixed infections.

Q: Why is a combination drug like Неотризол prescribed instead of two separate medicines?

A: Official information describes this product as a multi-component preparation intended to address complex or mixed infections simultaneously. The combination is designed to target multiple types of pathogens, including fungi, bacteria, and protozoa, with a single, comprehensive course of treatment.

Q: How quickly should a patient expect to see improvement after starting Неотризол?

A: The product contains Prednisolone, a corticosteroid, which is included specifically to provide a rapid local anti-inflammatory effect. This action is intended to quickly reduce symptoms like swelling, redness, and irritation, which may lead to early symptom relief.

Q: Are there any significant drug interactions that official sources mention for Неотризол?

A: Yes. Official documents detail significant interactions, including enhanced effects of oral anticoagulants (e.g., Warfarin) and enhanced toxicity risk with other neurotoxic or nephrotoxic agents.

Q: Do people with a history of blood disorders have to use caution with Неотризол?

A: Official guidance advises that patients with a history of blood disorders (dyscrasias) should exercise caution. Regulatory precautions associated with the Ornidazole component may require checking leukocyte counts (white blood cell counts) before and after starting treatment.

Q: What are the official warnings about symptoms like numbness or tingling in the extremities?

A: Official safety profiles for the Ornidazole component list numbness or tingling of the fingers or toes (peripheral neuropathy) as a known, though often rare, adverse event. Patients should be aware of this potential neurological side effect.

Q: Is it safe to use during the menstrual period?

A: Administration of the vaginal suppository is generally not recommended during the menstrual period. This is noted as a precaution, often related to the potential for reduced efficacy of the treatment, as the menstrual flow may interfere with the medication’s action.

Q: Why do some people report dizziness or headache while using Неотризол?

A: The Ornidazole component, which is absorbed systemically in small amounts, is associated with neurological side effects. These can include common events like headache and dizziness, as well as occasional reports of somnolence (drowsiness).

Q: Are mood changes or feelings of dizziness reported with the use of Неотризол?

A: Side effects associated with the Ornidazole component include dizziness and, in rare instances, more significant neurological effects like mental confusion. These reported effects relate to its potential to influence the Central Nervous System.

Q: Is special hygiene required during or after using Неотризол?

A: Guidance generally advises avoiding the concurrent use of other vaginal products, such as douches, during treatment, as these could interfere with the medication's intended action. Standard hygiene practices are generally recommended.

Q: Are there specific food items or supplements that interact with Неотризол?

A: The key interaction cited in official documents is the strict necessity to avoid Alcohol (Ethanol) during treatment and for a specified period afterward. Most official documents do not cite specific common food or supplement interactions, other than those containing alcohol.

Q: Can Неотризол cause temporary changes in urine color?

A: Medicines that belong to the nitroimidazole class, which includes the Ornidazole component, are known to occasionally cause a harmless, temporary darkening or discoloration of the urine in some patients due to a change in how the body processes the drug.

Q: What are the symptoms of an overdose of Неотризол that are officially reported?

A: While systemic toxicity from a vaginal overdose is rare, the most serious potential symptoms would be those associated with the systemic absorption of Neomycin. This includes the potential for ototoxicity (issues with hearing or balance) or nephrotoxicity (effects on the kidneys).

Q: Does the efficacy of Неотризол depend on taking it at a specific time of day?

A: Yes. Official administration instructions specify that the suppository should be used at night, before bedtime, while in a lying position. This timing and position are directed to ensure the suppository remains in the vagina for a sufficient period for optimal absorption and distribution.

Q: What is the typical course length for Неотризол as described in official documents?

A: The specific numeric total duration of treatment is established by the local national regulatory authority and must be followed exactly as prescribed. Generally, the treatment is classified as a fixed, short-term course.

Q: Can Неотризол be used for recurring infections?

A: Official prescribing information is primarily for acute, mixed infections. Research documents note that the evidence base regarding the medicine’s use for recurrent or chronic forms of these conditions is limited.

Q: Can stopping the medication early affect the success of Неотризол treatment?

A: Official guidance emphasizes the importance of completing the full prescribed course of treatment, even if symptoms show improvement quickly, which is a strategy intended to help ensure the full elimination of the infection.

Q: Are there warnings about using Неотризол for people with certain neurological conditions?

A: Yes. Certain CNS diseases (Central Nervous System diseases) such as Epilepsy and conditions like multiple sclerosis are specifically mentioned in official warnings. Caution is required or use may be contraindicated due to the potential neurological effects of the Ornidazole component.

Q: Does Неотризол have an effect on thyroid or adrenal function, according to precautions?

A: The Prednisolone component is a corticosteroid. With prolonged or excessive use, official information notes a theoretical potential risk of HPA axis suppression, which describes a change in the body's natural adrenal hormone production.

Q: Is special caution required for people with advanced age using Неотризол?

A: Official regulatory documents cite that the overall risk profile is potentially heightened in patient populations of advanced age. This is a precaution that recognizes potential changes in drug metabolism or underlying health conditions in this group.

Q: Do studies exist that examine the long-term effects of Неотризол use?

A: Research documentation states that the long-term effects are not fully established for this specific combination product. Studies have not yet determined long-term patterns of response or safety after six months or a year of use.

Q: What official information exists about taking blood thinners concurrently with Неотризол?

A: Official documents confirm that the Miconazole component can increase the plasma concentration and effect of oral anticoagulants (commonly referred to as blood thinners like Warfarin). This means official caution is required, and any changes must be managed by a healthcare provider.

Q: Is it common for people to experience a dry mouth or constipation with Неотризол?

A: Dry mouth is a reported side effect associated with the Ornidazole component, although it may be less common with topical administration. Constipation is not typically listed as a primary side effect in official documents.

Q: Does Неотризол affect the body's immune system?

A: The Prednisolone component is a corticosteroid. It acts as a local anti-inflammatory agent by modulating the expression of genes involved in the inflammatory response. This targets the local symptoms of irritation and swelling.

Advertisements

How should Неотризол be stored and disposed of?

Official Storage and Disposal Requirements

Неотризол (vaginal suppositories) must be stored and handled according to regulatory guidelines to ensure stability and public safety.

Condition Type Requirement
Temperature Store at Controlled Room Temperature, typically 15 C to 30 C (59 F to 86 F).
Protection Do not freeze. Keep away from excess heat and moisture.
Container Store in the original container and keep it tightly closed.
Child Safety Keep out of the reach of children.

Disposal Instructions:

Outdated or unused Неотризол should be discarded by following official guidelines for pharmaceutical waste. Users are instructed to utilize a drug take-back program if one is available in the area. If not, follow national regulatory procedures, such as those provided by the FDA, for safe disposal in household trash to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Неотризол found in:

A-Z Index: